1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Technetium Tc 99m-labeled Tilmanocept: new trials by email Literature Review of Technetium Tc 99m-labeled Tilmanocept trials Research Report on Technetium Tc 99m-labeled Tilmanocept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial Biospecimen Collection, Carboplatin, Cisplatin - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8 | Phase 2 | Recruiting | University of Michigan Rogel Cancer Center | 50 | 2025-07-17 | 2026-07-31 |
| Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer Panitumumab-IRDye800, Lymphoseek - Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 2 | Completed | Eben Rosenthal | 3 | 2019-08-01 | 2022-11-10 |
Squamous Cell Carcinoma of Head and Neck (2) · Head and Neck Neoplasms (1) · Mouth Neoplasms (1)
Eben Rosenthal (1) · University of Michigan Rogel Cancer Center (1)
United States (2)
Fred M Baik (1) · Jennifer L Shah (1)
P30CA124435 (1), R01CA190306 (1)